Editas Medicine, Inc. Financial Ratios — EDIT Stock

Profitability	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-186.58	-90.25	-51.35	-39.95	-27.71	-28.79	-21.45	-30.8	-36.99	-30.24	-56.4
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	- -	- -	-2,138.8	-1,585.76	-854.09	-345.91	-672.6	-144.25	-736.35	-1,114.11	-208.8	-721.39
Operating Margin (%)	- -	- -	-2,167.71	-1,605.62	-873.64	-356.1	-686.39	-148.61	-756.13	-1,146.26	-216.56	-739.37
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-4,475.14	-1,605.53	-876.49	-344.28	-651.43	-127.82	-753.61	-1,118.26	-196.13	-733.72
Profit Margin (%)	- -	- -	-4,475.14	-1,605.53	-876.49	-344.28	-651.43	-127.82	-753.61	-1,118.26	-196.13	-733.72
Net Income to Common Margin (%)	- -	- -	-4,499.32	-1,606.31	-876.49	-344.28	-651.43	-127.82	-753.61	-1,118.26	-196.13	-733.72
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	-7.34	0.54	0.05	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	2	- -	200	45	41	32	29	26	26	44	37	35
LT Debt	2	- -	200	35	33	32	23	19	16	33	24	20
ST Debt	- -	- -	- -	10	8	- -	6	7	10	11	12	15
Total Debt/EBITDA	- -	-0.03	-5.74	-0.47	-0.35	-0.29	-0.21	-0.2	-0.14	-0.2	-0.22	-0.15
Net Debt/EBITDA	- -	0.81	-1.63	1.83	1.19	1.22	1.72	1.07	1.08	0.64	0.76	0.56
Total Debt/EBIT	- -	-0.03	-5.66	-0.46	-0.34	-0.29	-0.21	-0.19	-0.14	-0.19	-0.22	-0.15
Net Debt/EBIT	- -	0.8	-1.61	1.8	1.16	1.19	1.69	1.04	1.05	0.63	0.73	0.55
EBITDA to Interest Expense	- -	-369.59	-243.64	1,548.16	-119.89	32.07	18.88	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	-405.38	-253.65	1,604.5	-121.99	33.45	19.73	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	-374.21	-246.94	1,567.55	-122.63	33.01	19.27	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	1	-3	-7	- -	- -	- -	- -	- -
Common Equity/Total Assets	-71.06	-126.75	-59.15	-80.95	-81.94	-99.02	-107.93	-116.17	-126.6	-209.62	-246.69	-429.88
Long-Term Debt/Equity (%)	- -	- -	- -	26.07	16.07	13.73	8.87	4.91	2.9	9.11	6.98	15.18
Long-Term Debt/Capital (%)	606.61	-2.29	179.19	-24.99	-12.62	-8.45	-4.48	-3.02	-1.93	-3.18	-2.04	-1.42
Long-Term Debt/Total Assets (%)	85.09	2.82	133.85	15.31	8.96	7.71	4.57	3.37	2.37	6.39	4.88	5.97
Total Debt/Equity (%)	-119.74	-2.69	-240.53	33.5	19.67	13.73	11.08	6.64	4.76	12.18	10.47	26.09
Total Debt/Capital (%)	606.61	-2.73	179.19	-32.11	-15.45	-8.45	-5.59	-4.09	-3.17	-4.25	-3.06	-2.44
Total Debt/Total Assets (%)	85.09	3.37	133.85	19.68	10.97	7.71	5.71	4.56	3.89	8.54	7.32	10.26
Net Debt to Equity	-5.62	66.78	-68.26	-130.25	-66.86	-57.07	-90.76	-35.49	-36.76	-39.24	-35.42	-97.96
Net Debt/Capital (%)	-5.95	39.8	-179.47	53.82	33.81	25.99	31.41	17.94	19.67	12.04	9.38	8.41
EBITDA	- -	-13	-35	-96	-117	-110	-138	-131	-188	-220	-163	-233
EBITDA-CapEx	- -	-14	-36	-99	-119	-115	-144	-138	-196	-224	-168	-242
Operating Income (Loss)	- -	-13	-35	-97	-120	-114	-141	-135	-193	-226	-169	-239

Liquidity	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	0.95	1.72	20.68	5.6	8.97	10.28	7.62	6.91	10.66	5.73	5.11	3.5
Current Ratio	0.98	1.74	20.94	5.66	9.05	10.44	7.74	7.2	10.82	5.94	5.39	3.75
Quick Ratio	0.95	1.72	20.82	5.6	8.99	10.28	7.63	7.01	10.67	5.81	5.27	3.71
CFO/Avg Current Liab	- -	-2.09	-0.83	-2.51	-0.27	-1.26	-0.85	-3.04	-3.12	-3.32	-2.14	-2.99
Common Equity/Total Assets	-71.06	-126.75	-59.15	-80.95	-81.94	-99.02	-107.93	-116.17	-126.6	-209.62	-246.69	-429.88
Long-Term Debt/Equity (%)	- -	- -	- -	26.07	16.07	13.73	8.87	4.91	2.9	9.11	6.98	15.18
Long-Term Debt/Capital (%)	606.61	-2.29	179.19	-24.99	-12.62	-8.45	-4.48	-3.02	-1.93	-3.18	-2.04	-1.42
Long-Term Debt/Total Assets (%)	85.09	2.82	133.85	15.31	8.96	7.71	4.57	3.37	2.37	6.39	4.88	5.97
Total Debt/Equity (%)	-119.74	-2.69	-240.53	33.5	19.67	13.73	11.08	6.64	4.76	12.18	10.47	26.09
Total Debt/Capital (%)	606.61	-2.73	179.19	-32.11	-15.45	-8.45	-5.59	-4.09	-3.17	-4.25	-3.06	-2.44
Total Debt/Total Assets (%)	85.09	3.37	133.85	19.68	10.97	7.71	5.71	4.56	3.89	8.54	7.32	10.26
CFO/Total Liabilities	- -	-31.5	-2.34	-53.13	-5.7	-24.81	-16.5	-100.46	-132.27	-115.43	-88.09	-101.43
CFO/CapEx	- -	-7.11	-3.8	-14.38	-4.57	-9.61	-6.59	-25.11	-20.53	-43.07	-28.01	-23.83
Altman's Z-Score	-1.01	-4.77	-0.49	1.62	3.28	2.25	2.17	12.28	6.84	-1.28	-0.67	-7.18

Working Capital	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	3.2	10.94	35.8	90.09	91.66	28.06	8.09	7.28	10.19	2.44
Days Sales Outstanding	- -	- -	114.16	33.38	10.2	4.05	3.98	13.01	45.12	50.11	35.82	149.4
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	- -	523	1,239	1,071	1,480	4,109	1,795	609	770	105
- Cash & Cash Equivalents	2	11	143	185	147	135	238	140	204	142	124	132
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	- -	200	45	41	32	29	26	26	44	37	35
Enterprise Value	- -	-10	57	383	951	735	1,052	3,733	1,322	309	483	-130
Total Capital	- -	-15	112	-140	-265	-384	-520	-639	-831	-1,034	-1,195	-1,433
Total Debt/Capital (%)	606.61	-2.73	179.19	-32.11	-15.45	-8.45	-5.59	-4.09	-3.17	-4.25	-3.06	-2.44
Total Debt / EV	21.32	-0.04	3.52	0.12	0.04	0.04	0.03	0.01	0.02	0.14	0.08	-0.27
EV/Sales	- -	- -	34.83	63.22	69.27	23.01	51.24	41.14	51.75	15.66	6.18	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	523	1,239	1,071	1,480	4,109	1,795	609	770	105
Diluted Enterprise Value	- -	-10	57	383	1,133	969	1,271	3,996	1,618	511	682	8
EV per Share	- -	- -	1.59	11.88	23.58	15.6	21.05	63.7	19.55	4.5	6.36	- -
TTM Sales	- -	- -	2	6	14	32	21	91	26	20	78	32
TTM EBITDA	- -	-13	-35	-96	-117	-110	-138	-131	-188	-220	-163	-233
TTM Operating Income	- -	-13	-35	-97	-120	-114	-141	-135	-193	-226	-169	-239
TTM Cash Flow to Firm	- -	-9	-5	-50	-8	-49	-48	-180	-164	-177	-132	-210
TTM Free Cash Flow to Firm	- -	-7	-4	-47	-6	-44	-42	-173	-156	-173	-127	-201

Multiples	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-7.86	-6.95	-13.98	-9	-15.83	-16.05	-4.56	-4.33	-1.8
Price/Earnings High	- -	- -	- -	-14.58	-11.01	-19.28	-12.27	-48.74	-35.11	-8.72	-5.91	-4.02
Price/Earnings Low	- -	- -	- -	-4.12	-4.4	-7.62	-7.1	-7.08	-9.31	-2.56	-3.01	-0.4
Price/Book Value	- -	- -	- -	-2.82	-4.05	-2.57	-2.69	-6.18	-2.09	-0.56	-0.62	-0.07
Price/Book Value Average	- -	- -	- -	-4.12	-2.73	-3.69	-2.19	-2.76	-3.6	-0.93	-0.54	-0.29
Price/Book Value High	- -	- -	- -	-7.64	-4.33	-5.09	-2.99	-8.5	-7.88	-1.78	-0.74	-0.65
Price/Book Value Low	- -	- -	- -	-2.16	-1.73	-2.01	-1.73	-1.23	-2.09	-0.52	-0.38	-0.07
Price/Tangible Book Value	- -	- -	- -	3.88	5.96	4.54	5.64	10.44	3.24	1.69	2.2	0.78
Price/Tangible Book Value Average	- -	- -	- -	5.68	4.02	6.51	4.59	4.66	5.58	2.79	1.9	3.17
Price/Tangible Book Value High	- -	- -	- -	10.53	6.37	8.98	6.25	14.36	12.21	5.33	2.6	7.1
Price/Tangible Book Value Low	- -	- -	- -	2.98	2.54	3.55	3.62	2.09	3.24	1.56	1.32	0.71
Price/Sales	- -	- -	- -	86.39	90.26	33.55	72.09	45.29	70.28	30.9	9.85	3.24
Price/Sales Average	- -	- -	- -	126.22	60.92	48.12	58.62	20.23	120.93	50.96	8.5	13.18
Price/Sales High	- -	- -	- -	234.16	96.49	66.39	79.9	62.3	264.58	97.5	11.6	29.51
Price/Sales Low	- -	- -	- -	66.16	38.54	26.25	46.26	9.05	70.18	28.59	5.91	2.96
Price/Cash Flow	- -	- -	- -	-10.41	-131.59	-23.44	-36.39	-22.85	-10.96	-3.43	-5.82	-0.5
Price/Cash Flow Average	- -	- -	- -	-15.21	-88.81	-33.62	-29.59	-10.21	-18.86	-5.66	-5.02	-2.03
Price/Cash Flow High	- -	- -	- -	-28.21	-140.66	-46.39	-40.34	-31.43	-41.26	-10.84	-6.85	-4.53
Price/Cash Flow Low	- -	- -	- -	-7.97	-56.18	-18.34	-23.35	-4.57	-10.94	-3.18	-3.49	-0.45
Price/Free Cash Flow	- -	- -	- -	-11.18	-168.41	-26.16	-42.9	-23.8	-11.52	-3.52	-6.04	-0.52
Price/Free Cash Flow Average	- -	- -	- -	-16.34	-113.66	-37.53	-34.88	-10.63	-19.82	-5.8	-5.21	-2.11
Price/Free Cash Flow High	- -	- -	- -	-30.32	-180.03	-51.77	-47.55	-32.74	-43.37	-11.09	-7.11	-4.73
Price/Free Cash Flow Low	- -	- -	- -	-8.57	-71.9	-20.47	-27.53	-4.76	-11.5	-3.25	-3.62	-0.47
EV/Sales	- -	- -	34.83	63.22	69.27	23.01	51.24	41.14	51.75	15.66	6.18	- -
EV/Sales Average	- -	- -	34.83	103.05	53.22	44.91	48.44	18.98	113.99	46.01	7.38	10.2
EV/Sales High	- -	- -	34.83	210.99	88.79	63.19	69.72	61.05	257.65	92.55	10.48	26.52
EV/Sales Low	- -	- -	34.83	43	30.84	23.04	36.07	7.8	63.24	23.64	4.8	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	0.81	-1.63	-6.5	-6.23	-12.98	-7.2	-13.16	-15.48	-4.13	-3.54	-1.41
EV/EBITDA High	- -	0.81	-1.63	-13.31	-10.4	-18.27	-10.37	-42.32	-34.99	-8.31	-5.02	-3.68
EV/EBITDA Low	- -	0.81	-1.63	-2.71	-3.61	-6.66	-5.36	-5.41	-8.59	-2.12	-2.3	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	0.8	-1.61	-6.42	-6.09	-12.61	-7.06	-12.77	-15.08	-4.01	-3.41	-1.38
EV/EBIT High	- -	0.8	-1.61	-13.14	-10.16	-17.74	-10.16	-41.08	-34.07	-8.07	-4.84	-3.59
EV/EBIT Low	- -	0.8	-1.61	-2.68	-3.53	-6.47	-5.26	-5.25	-8.36	-2.06	-2.22	- -
Last Price	- -	- -	- -	16.23	30.73	22.75	29.61	70.11	26.55	8.87	10.13	1.27
High Price	- -	- -	- -	43.99	32.85	45.02	32.82	96.45	99.95	27.99	11.93	11.58
Low Price	- -	- -	- -	12.43	13.12	17.8	19	14.01	26.51	8.21	6.08	1.16
Enterprise Value	- -	-10	57	383	951	735	1,052	3,733	1,322	309	483	-130
Enterprise Value Average	- -	-10	57	624	731	1,434	994	1,722	2,912	907	577	330
Enterprise Value High	- -	-10	57	1,277	1,219	2,018	1,431	5,539	6,581	1,824	819	857
Enterprise Value Low	- -	-10	57	260	423	736	741	708	1,615	466	375	-1

Per Share Data Items	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	36	36	36	36	45	49	54	63	68	69	82	83
Diluted Weighted Avg Shares	- -	15	36	32	40	47	50	59	68	69	76	82
Basic Weighted Avg Shares	- -	15	36	32	40	47	50	59	68	69	76	82
Revenue per Share	- -	- -	0.05	0.19	0.34	0.68	0.41	1.55	0.38	0.29	1.03	0.39
EBITDA per Share	- -	-0.81	-0.98	-2.98	-2.91	-2.35	-2.76	-2.23	-2.78	-3.2	-2.15	-2.83
Operating Income per Share	- -	-0.82	-0.99	-3.02	-2.97	-2.41	-2.82	-2.3	-2.86	-3.29	-2.23	-2.9
Basic EPS, GAAP	- -	-0.83	-2.05	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88
Basic EPS from Cont Ops	- -	-0.89	-2.04	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88
Diluted EPS, GAAP	- -	-0.83	-2.05	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88
Diluted EPS from Cont Ops	- -	-0.89	-2.04	-3.02	-2.98	-2.33	-2.68	-1.98	-2.85	-3.21	-2.02	-2.88
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-0.56	-0.15	-1.56	-0.23	-0.97	-0.81	-3.07	-2.42	-2.58	-1.74	-2.55
Free Cash Flow per Basic Share	- -	-0.64	-0.19	-1.67	-0.28	-1.07	-0.94	-3.19	-2.54	-2.64	-1.8	-2.66
Cash & Equivalents per Share	- -	0.69	4.01	5.75	8.16	7.83	9.15	6.86	7.39	5.01	4.25	3.28
Book Value per Share	- -	-1	-2.47	-5.76	-7.58	-8.84	-10.99	-11.35	-12.68	-15.7	-16.21	-17.83
Tangible Book Value per Share	- -	-0.99	-2.33	4.18	5.16	5.01	5.25	6.72	8.19	5.25	4.6	1.63

Editas Medicine, Inc.

Profitability

Credit

Liquidity

Working Capital

Enterprise Value

Multiples

Per Share Data Items